Luis A. Diaz Jr.

Dr. Luis A. Diaz Jr. is a prominent oncologist and researcher at Memorial Sloan Kettering Cancer Center, known for his innovative work in the field of cancer immunotherapy. His research has significantly advanced the understanding and application of immunotherapies in treating solid tumors, particularly in patients who have limited treatment options. Diaz's leadership in clinical trials, such as those involving the drug dostarlimab, has paved the way for new approaches that spare patients from the harsh effects of traditional cancer therapies.